PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
about
Immunity and Tolerance Induced by Intestinal Mucosal Dendritic CellsCritical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell developmentThe dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed settingFunctional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome.Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells.Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.Optimizing dendritic cell-based approaches for cancer immunotherapyBcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivoCocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155.A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin States.Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.Transcriptional regulation of dendritic cell diversity.Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathwaysA STATus report on DC development.Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development.Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogenyDynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cellsRe(de)fining the dendritic cell lineage.The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2.Dendritic cell homeostasis.The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.Transcriptional Control of Dendritic Cell Development.Mechanisms regulating dendritic cell specification and developmentTranscription factor networks in dendritic cell development.The role of dendritic cells in graft-versus-tumor effectFate mapping of dendritic cells.Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and toleranceThe signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs.E-box protein E2-2 is a crucial regulator of plasmacytoid DC development.The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?Dendritic cell development: a choose-your-own-adventure story.Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow.
P2860
Q26749134-C90EABD0-3131-4EB3-847E-2FE0D0615CE3Q28591631-99BF5261-AD94-4980-A797-FF5D2F4279CDQ29618424-10A3CFA8-9F67-4C96-9411-804845C5EF75Q33659579-D95B8F46-CE87-46E4-B37E-7FE5E76735DDQ34398362-B9B7C1E7-3968-4282-A1D1-5CEE7B87EEFCQ34490196-A20CBF94-316D-437B-AE44-8E3842515B15Q34624167-6BD10ABF-FE1B-4528-9D35-421C160D978FQ34637535-8ADE421F-FD05-4C3E-8531-1438801DAEE8Q34760844-AB6C4E1F-A9C8-4DBE-B027-4079B0A1BC00Q35082573-4D9CC8E7-5B4C-4B23-AE86-2F945490BA92Q35546675-047B14BA-B1EE-4792-885C-EEF551E68D32Q35791588-058E607E-7B7A-43E9-8999-2A38D1976B2EQ35927398-3817991C-C267-43C0-8E2E-1F0854A6A5BDQ35996976-F52C2489-D7D1-481B-BBC2-8557EA4F8942Q36010305-7932B63A-F2AC-49B3-8BE4-A694DF0AE384Q36141633-A8AD27DC-4F99-44B4-B541-7878C2700FA5Q36188887-DF486C35-0E6F-459B-ABC8-E5C49E9EE16BQ36227877-2A79B992-8F72-459F-AB69-8B179C909D9BQ36263627-5DC66E63-0D9F-4865-9331-9EE4A443A415Q36402594-0E3F4E9A-6932-4F24-97F7-B0FAF98EC415Q36602150-B1AF42FE-A014-457B-B1E3-0C2E97A82D5BQ36818027-39267D29-0B50-4391-806D-1EED29135CD7Q36969029-A7FCC4D3-873F-484E-974E-75C368301A6AQ37095249-F6167DF8-ABC9-41D3-901A-BD4FC4096F1FQ37157975-056B6579-219A-4025-A507-BDE48F9C56F6Q37262669-36C33DB1-9910-487C-80F2-C1CACE1F0A21Q37468541-BEC45EAE-6D15-405E-892D-3F2BE4BB38DAQ37802420-698E2FAE-56DD-43BF-8398-DDC188E29469Q37933760-A0637B2D-B192-4B43-92FC-048ED7F66899Q38193807-50A72EB0-9EE0-454B-ADF0-F68744177AA5Q38497229-5AA63A7D-8E84-4C58-A895-F8CBB8F251EDQ38540521-75CC7872-2EC8-4725-9E72-3291725FF3A4Q38719738-78EF669E-CFE9-4E1A-A4E5-3A9405FEEF4DQ40352693-D4EB9DCA-48F0-4411-A683-F2AC20CE044BQ40450464-4E5F8628-B523-4326-80E1-13491CDFE165Q40656625-DBCB1B5F-0CD7-4860-9774-F3C11DDAAA37Q40770329-4265F6E4-CAE0-43AE-AB98-9DD0DD70108FQ41352500-1FB5347A-9C52-4741-993D-8C39615B2738Q41610273-2583BC3F-185A-466F-A460-9A535F4F6100Q41872369-08C2F0D8-2BC9-4460-A392-DE5B7B55D138
P2860
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
description
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Februar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/02/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/02/01)
@nl
наукова стаття, опублікована в лютому 2000
@uk
مقالة علمية (نشرت في فبراير 2000)
@ar
name
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@ast
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@en
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@nl
type
label
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@ast
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@en
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@nl
prefLabel
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@ast
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@en
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@nl
P2093
P921
P3181
P1433
P1476
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
@en
P2093
P304
P3181
P407
P577
2000-02-01T00:00:00Z